Permissive hyperglycemia in extremely low birth weight infants

Journal of Korean Medical Science

Volumn 28, Issue 3, 2013, Pages 450-460

  Yoo, Hye Soo ^a   Ahn, So Yoon ^a   Lee, Myung Sook ^a   Han, Young Mi ^a   Sung, Se In ^a   Chang, Yun Sil ^a   Park, Won Soon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Extremely low birth weight; Hyperglycemia; Infant; Prognosis

Indexed keywords

ANTIDIABETIC AGENT;

ARTICLE; BLOOD; DEMOGRAPHY; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MORTALITY; NEWBORN; NEWBORN INTENSIVE CARE; PATHOLOGY; PREMATURITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK; TIME;

HYPERGLYCEMIA; INFANT, EXTREMELY LOW BIRTH WEIGHT; PROGNOSIS;

BLOOD GLUCOSE; DEMOGRAPHY; GESTATIONAL AGE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; ODDS RATIO; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84875795975     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.3.450     Document Type: Article

References (39)

1. Dweck HS, Cassady G. Glucose intolerance in infants of very low birth weight: I. incidence of hyperglycemia in infants of birth weights 1,100 grams or less. Pediatrics 1974; 53: 189-95.
2. Binder ND, Raschko PK, Benda GI, Reynolds JW. Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia. J Pediatr 1989; 114: 273-80.
3. Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006; 118: 1811-8.
4. Garg R, Agthe AG, Donohue PK, Lehmann CU. Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J Perinatol 2003; 23: 186-94.
5. Decaro MH, Vain NE. Hyperglycaemia in preterm neonates: what to know, what to do. Early Hum Dev 2011; 87: S19-22.
6. Hay WW Jr. Addressing hypoglycemia and hyperglycemia. Pediatr Rev 1999; 20: e4-5.
7. Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med 2005; 10: 377-87.
8. Hemachandra AH, Cowett RM. Neonatal hyperglycemia. Pediatr Rev 1999; 20: e16-24.
9. Kairamkonda VR, Khashu M. Controversies in the management of hyperglycemia in the ELBW infant. Indian Pediatr 2008; 45: 29-38.
10. Coulthard MG, Hey EN. Renal processing of glucose in well and sick neonates. Arch Dis Child Fetal Neonatal Ed 1999; 81: F92-8.
11. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, van Weissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008; 359: 1873-84.
12. Han BR, Oh YS, Ahn KH, Kim HY, Hong SC, Oh MJ, Kim HJ, Kim YT, Lee KW, Kim SH. Clinical implication of 2nd trimester glycosuria. Korean J Perinatol 2010; 21: 258-65.
13. Pati NK, Maheshwari R, Pati NK, Salhan RN. Transient neonatal hyperglycemia. Indian Pediatr 2001; 38: 898-901.
14. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966; 37: 403-8.
15. Bae CW, Hahn WH. Surfactant therapy for neonatal respiratory distress syndrome: a review of Korean experiences over 17 years. J Korean Med Sci 2009; 24: 1110-8.
16. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K; National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-60.
17. Choi CW, Kim BI, Kim EK, Song ES, Lee JJ. Incidence of bronchopulmonary dysplasia in Korea. J Korean Med Sci 2012; 27: 914-21.
18. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529-34.
19. Lee JY, Kim HS, Jung E, Kim ES, Shim GH, Lee HJ, Lee JA, Choi CW, Kim EK, Kim BI, et al. Risk factors for periventricular-intraventricular hemorrhage in premature infants. J Korean Med Sci 2010; 25: 418-24.
20. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1-7.
21. An international classification of retinopathy of prematurity: the Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 1984; 102: 1130-4.
22. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins RD; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-65.
23. Leonard CH, Piecuch RE, Cooper BA. Use of the Bayley Infant Neurodevelopmental Screener with low birth weight infants. J Pediatr Psychol 2001; 26: 33-40.
24. Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003; 112: 33-9.
25. Xu FL, Duan JJ, Zhang YH, Zhang XL, Guo JJ. Risk factors for periventricular- intraventricular hemorrhage in premature infants treated with mechanical ventilation. Zhongguo Dang Dai Er Ke Za Zhi 2012; 14: 838-41.
26. Embleton NE, Pang N, Cooke RJ. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants. Pediatrics 2001; 107: 270-3.
27. Levitsky DA, Strupp BJ. Malnutrition and the brain: changing concepts, changing concerns. J Nutr 1995; 125: 2212S-20.
28. Grantham-McGregor S. A review of studies of the effect of severe malnutrition on mental development. J Nutr 1995; 125: 2233S-8.
29. Dobbing J. Nutritional growth restriction and the nervous system. In: Davidson AN, Thompson RH, editors. The molecular basis of neuropathology. 2nd ed. London: Edward Arnold, 1981.
30. Coulthard MG, Hey EN. Effect of varying water intake on renal function in healthy preterm babies. Arch Dis Child 1985; 60: 614-20.
31. Cowett RM, Oh W, Schwartz R. Persistent glucose production during glucose infusion in the neonate. J Clin Invest 1983; 71: 467-75.
32. Ditzenberger GR, Collins SD, Binder N. Continuous insulin intravenous infusion therapy for VLBW infants. J Perinat Neonatal Nurs 1999; 13: 70-82.
33. Louaib D, Lachassinne E, Nathanson M, Muller MH, Sauvion S, Gaudelus J. Hyperglycemia revealing neonatal infection. Arch Pediatr 1994; 1: 819-21.
34. Koivisto M, Peltoniemi OM, Saarela T, Tammela O, Jouppila P, Hallman M. Blood glucose level in preterm infants after antenatal exposure to glucocorticoid. Acta Paediatr 2007; 96: 664-8.
35. Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001; 50: 2279-86.
36. Blanco CL, Baillargeon JG, Morrison RL, Gong AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006; 26: 737-41.
37. Collins JW Jr, Hoppe M, Brown K, Edidin DV, Padbury J, Ogata ES. A controlled trial of insulin infusion and parenteral nutrition in extremely low birth weight infants with glucose intolerance. J Pediatr 1991; 118: 921-7.
38. Poindexter BB, Karn CA, Denne SC. Exogenous insulin reduces proteolysis and protein synthesis in extremely low birth weight infants. J Pediatr 1998; 132: 948-53.
39. Gibson AT, Carney S, Cavazzoni E, Wales JK. Neonatal and post-natal growth. Horm Res 2000; 53: 42-9.